Qingdao Vland Biotech INC. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 829.41 million compared to CNY 832.64 million a year ago. Revenue was CNY 829.41 million compared to CNY 832.64 million a year ago.

Net income was CNY 54.21 million compared to CNY 94.5 million a year ago. Basic earnings per share from continuing operations was CNY 0.22 compared to CNY 0.39 a year ago. Diluted earnings per share from continuing operations was CNY 0.22 compared to CNY 0.39 a year ago.